Financhill
Sell
37

TOI Quote, Financials, Valuation and Earnings

Last price:
$3.54
Seasonality move :
14.24%
Day range:
$3.30 - $3.39
52-week range:
$0.20 - $4.88
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.63x
P/B ratio:
75.34x
Volume:
780.6K
Avg. volume:
2.5M
1-year change:
1556.05%
Market cap:
$332.5M
Revenue:
$393.4M
EPS (TTM):
-$0.64

Earnings Data

Next earnings date for TOI
Mar 23
2026
Most recent earnings per share
-$0.14
Missed by $0.14
(Nov 13/2025)
Consensus Estimate
--
(Nov 13/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

TOI Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/23/2026 Q4 $139.8M -- -- -- --
11/13/2025 Q3 $122.6M $136.6M -$0.14 -- --
08/13/2025 Q2 $113.2M $119.8M -$0.15 -- --
05/13/2025 Q1 -- $104.4M -$0.21 -- --
03/24/2025 Q4 -- $100.3M -$0.14 -- --
11/13/2024 Q3 -- $99.9M -$0.18 -- --
08/13/2024 Q2 $103.3M $98.6M -$0.17 -$0.10 -$0.07
05/14/2024 Q1 $95.2M $94.7M -$0.22 -$0.12 -$0.10
03/27/2024 Q4 $82M $85.8M -$0.21 -$0.11 -$0.10
11/08/2023 Q3 $74.7M $82M -$0.19 -$0.13 -$0.06
08/08/2023 Q2 -- $80.2M -$0.19 -- --
05/10/2023 Q1 -- $76.2M -$0.33 -- --
03/09/2023 Q4 -- $71.4M -$0.15 -- --
11/09/2022 Q3 -- $65M -$0.17 -- --
08/09/2022 Q2 -- $60.9M -$0.06 -- --
05/11/2022 Q1 -- $55.2M $0.25 -- --
03/10/2022 Q4 -- $52.3M -$0.15 -- --
09/30/2021 Q3 -- $52.3M -$0.05 -- --
06/30/2021 Q2 -- $49.8M $0.05 -- --
03/31/2021 Q1 -- $48.6M -$0.02 -- --
12/31/2020 Q4 -- $49M -$0.08 -- --
09/30/2020 Q3 -- -- -$0.08 -- --
06/30/2020 Q2 -- -- -$0.09 -- --
03/31/2020 Q1 -- -- -$0.03 -- --
12/31/2019 Q4 -- -- -- -- --
12/31/2018 Q4 -- $37.4M -$0.03 -- --

The Oncology Institute, Inc. Earnings Questions

  • How Much did The Oncology Institute, Inc. Generate in Revenue Last Quarter?

    The Oncology Institute, Inc. reported $136.6M worth of top line sales in its most recent quarter.

  • Did The Oncology Institute, Inc. Beat Earnings Last Quarter?

    The Oncology Institute, Inc. announced earnings per share of -$0.14 which represents a miss of analyst forecast a -- per share.

  • Is The Oncology Institute, Inc. Profitable?

    The Oncology Institute, Inc. reported $17.2M that represents $0.18 per share over the last quarter.

  • What is the Analyst Consensus for The Oncology Institute, Inc. EPS Next Year?

    The Oncology Institute, Inc.'s earnings are forecast to decrease from -$0.71 per share to -$0.51 per share next year representing a decrease of -54.35%.

  • When is The Oncology Institute, Inc.'s Earnings Date?

    The Oncology Institute, Inc.'s next earnings date is March 23, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
53
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 36x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
60
AAOI alert for Dec 24

Applied Optoelectronics, Inc. [AAOI] is up 5.1% over the past day.

Buy
85
HUT alert for Dec 24

Hut 8 Corp. [HUT] is up 0.65% over the past day.

Buy
63
GPCR alert for Dec 24

Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock